Detection of heterogeneous, intermediate-vancomycin-resistant Staphylococcus aureus (hVISA) using low-concentration vancomycin disks

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 37, Issue 4, 2006, Pages 761-767

  Lulitanond, Aroonlug ^a   Chanawong, Aroonwadee ^a   Sribenjalux, Pipat ^a   Kaewkes, Wanlop ^a   Vorachit, Malai ^b   Chongtrakool, Piriyaporn ^b   Leumsai, Danaisak ^a   Monpou, Pensri ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750206720     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bierbaum G, Fuchs K, Lenz W, Szekat C, Sahl HG. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur J Clin Microbiol Infect Dis 1999; 18: 691-6.
2. Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. Morb Mortal Wkly Rep 1997; 46: 765-6.
3. Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolution, epidemiologic and therapeutic Odyssey. Clin Infect Dis 2005; 40: 562-73.
4. Dos Santos Soares MJ, Da Silva-Carvalho MC, Ferreira-Carvalho BT, Figueiredo AM. Spread of methicillin-resistant Staphylococcus aureus belonging to the Brazilian epidemic clone in a general hospital and emergence of heterogeneous resistance to glycopeptide antibiotics among these isolates. J Hosp Infect 2000; 44: 301-8.
5. Ferraz V, Duse AG, Kassel M, Black AD, Ito T, Hiramatsu K. Vancomycin-resistant Staphylococcus aureus occurs in South Africa. S Afr Med J 2000; 90: 1113.
6. Hiramatsu K. Molecular evolution of MRSA. Microbiol Immunol 1995; 39: 531-43.
7. Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997a; 350: 1670-3.
8. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997b; 40: 135-6.
9. Rotun SS, McMath V, Schoonmaker DJ, et al. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia. Emerg Infect Dis 1999; 5: 147-9.
10. Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999; 340: 493-501.
11. Song JH, Hiramatsu K, Suh JY, et al. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2004; 48: 4926-8.
12. Tenover FC, Biddle JW, Lancaster MV. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis 2001; 7: 327-32.
13. Tenover FC, Lancaster MV, Hill BC, et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 1998; 36: 1020-7.
14. Tenover FC, Weigel LM, Appelbaum PC, et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 2004; 48: 275-80.
15. Van Belkum A, Verbrugh H. 40 years of methicillin-resistant Staphylococcus aureus. BMJ 2001; 323: 644-5.
16. Walsh TR, Bolmstrom A, Qwarnstrom A, et al. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 2001; 39: 2439-44.